Spectrum of Diffuse Parenchymal Lung Diseases Other than Idiopathic Pulmonary Fibrosis Based on Clinical, Radiological and Histopathological Correlation

Yosri Mohamed Kamel Akl, Ahmed Hussein Elhabashy, Nahed Mohamed Mostafa, Mohammed Kamal Hasswa, Sabah Ahmed Mohamed Hussein

2021, Vol: 12, Issue: 3

12 / 3Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

« Previous Article

Review Article

SRP. 2021; 12(3): 393-400

doi: 10.31838/srp.2021.3.60

Spectrum of Diffuse Parenchymal Lung Diseases Other than Idiopathic Pulmonary Fibrosis Based on Clinical, Radiological and Histopathological Correlation

Yosri Mohamed Kamel Akl, Ahmed Hussein Elhabashy, Nahed Mohamed Mostafa, Mohammed Kamal Hasswa, Sabah Ahmed Mohamed Hussein.

Abstract
Background: Multiple modalities are available for diagnosis of diffuse parenchymal lung diseases. High-resolution roles computed tomography of lung was well established in formulating initial cases diagnosis with diffuse parenchymal lung diseases. Major utilities of transbronchial lung biopsy rests in making possibilities specific diagnosis diffuse parenchymal lung diseases cases and avoiding a surgical lung biopsy.
Objectives and Methods: The aim of this work was to study the spectrum of diffuse parenchymal lung diseases other than idiopathic pulmonary fibrosis based on clinical, radiological and histopathological correlation. This study included 120patients with chest high resolution computed tomography signs of diffuse parenchymal lung diseases not consistent with idiopathic pulmonary fibrosis. Flexible bronchoscopy was done with the bronchoalveolar lavage and transbronchial lung biopsy were obtained. The samples were processed for cyto-histopathology.
Results: Nodular pattern (73.33%) was the most high-resolution computed tomography (HRCT) predominant pattern followed by ground glass pattern (45%) and reticular pattern (26.67%). The most frequent diagnosis was sarcoidosis(40.83%) followed by hypersensitivity pneumonitis (20%). The overall diagnostic yield of transbronchial lung biopsy was 79.1% (95/120). All differential diagnoses showed extreme matching between HRCT and histopathology.
Conclusion: HRCT is a non-invasive method to evaluate and diagnose patients with diffuse parenchymal lung diseases. Transbronchial lung biopsy found to have reliable yields in with diffuse parenchymal lung diseases diagnosis.

Key words: Diffuse parenchymal lung diseases, High resolution computed tomography, Histopathology

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Yosri Mohamed Kamel Akl Articles by Ahmed Hussein Elhabashy Articles by Nahed Mohamed Mostafa Articles by Mohammed Kamal Hasswa Articles by Sabah Ahmed Mohamed Hussein
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Yosri Mohamed Kamel Akl, Ahmed Hussein Elhabashy, Nahed Mohamed Mostafa, Mohammed Kamal Hasswa, Sabah Ahmed Mohamed Hussein. Spectrum of Diffuse Parenchymal Lung Diseases Other than Idiopathic Pulmonary Fibrosis Based on Clinical, Radiological and Histopathological Correlation. SRP. 2021; 12(3): 393-400. doi:10.31838/srp.2021.3.60

Web Style

Yosri Mohamed Kamel Akl, Ahmed Hussein Elhabashy, Nahed Mohamed Mostafa, Mohammed Kamal Hasswa, Sabah Ahmed Mohamed Hussein. Spectrum of Diffuse Parenchymal Lung Diseases Other than Idiopathic Pulmonary Fibrosis Based on Clinical, Radiological and Histopathological Correlation. http://www.sysrevpharm.org/?mno=54761 [Access: March 04, 2021]. doi:10.31838/srp.2021.3.60

AMA (American Medical Association) Style

Yosri Mohamed Kamel Akl, Ahmed Hussein Elhabashy, Nahed Mohamed Mostafa, Mohammed Kamal Hasswa, Sabah Ahmed Mohamed Hussein. Spectrum of Diffuse Parenchymal Lung Diseases Other than Idiopathic Pulmonary Fibrosis Based on Clinical, Radiological and Histopathological Correlation. SRP. 2021; 12(3): 393-400. doi:10.31838/srp.2021.3.60

Vancouver/ICMJE Style

Yosri Mohamed Kamel Akl, Ahmed Hussein Elhabashy, Nahed Mohamed Mostafa, Mohammed Kamal Hasswa, Sabah Ahmed Mohamed Hussein. Spectrum of Diffuse Parenchymal Lung Diseases Other than Idiopathic Pulmonary Fibrosis Based on Clinical, Radiological and Histopathological Correlation. SRP. (2021), [cited March 04, 2021]; 12(3): 393-400. doi:10.31838/srp.2021.3.60

Harvard Style

Yosri Mohamed Kamel Akl, Ahmed Hussein Elhabashy, Nahed Mohamed Mostafa, Mohammed Kamal Hasswa, Sabah Ahmed Mohamed Hussein (2021) Spectrum of Diffuse Parenchymal Lung Diseases Other than Idiopathic Pulmonary Fibrosis Based on Clinical, Radiological and Histopathological Correlation. SRP, 12 (3), 393-400. doi:10.31838/srp.2021.3.60

Turabian Style

Yosri Mohamed Kamel Akl, Ahmed Hussein Elhabashy, Nahed Mohamed Mostafa, Mohammed Kamal Hasswa, Sabah Ahmed Mohamed Hussein. 2021. Spectrum of Diffuse Parenchymal Lung Diseases Other than Idiopathic Pulmonary Fibrosis Based on Clinical, Radiological and Histopathological Correlation. Systematic Reviews in Pharmacy, 12 (3), 393-400. doi:10.31838/srp.2021.3.60

Chicago Style

Yosri Mohamed Kamel Akl, Ahmed Hussein Elhabashy, Nahed Mohamed Mostafa, Mohammed Kamal Hasswa, Sabah Ahmed Mohamed Hussein. "Spectrum of Diffuse Parenchymal Lung Diseases Other than Idiopathic Pulmonary Fibrosis Based on Clinical, Radiological and Histopathological Correlation." Systematic Reviews in Pharmacy 12 (2021), 393-400. doi:10.31838/srp.2021.3.60

MLA (The Modern Language Association) Style

APA (American Psychological Association) Style

Contact Information

<submissions.srp@gmail.com

How to cite this article

Copyright © 2019 Systematic Reviews in Pharmacy All Rights Reserved. Subject to change without notice from or liability to Systematic Reviews in Pharmacy.

Copyright © 2021 Systematic Reviews in Pharmacy All Rights Reserved. Subject to change without notice from or liability to Systematic Reviews in Pharmacy. For best results, please use Internet Explorer or Google Chrome	Contact Information <submissions.srp@gmail.com